News

Successful quality control in the pharmaceutical, chemical and life sciences industries requires active management

Quality control: If you want to achieve stable throughput times and reliable delivery capability, you need to consciously integrate flow physics into governance, planning and resource design.   Quality control: Why active process management is vital for pharmaceutical, chemical and life sciences industries.   The key points: From a queueing‑theory perspective, analytical QC laboratories are […]

Quality control: If you want to achieve stable throughput times and reliable delivery capability, you need to consciously integrate flow physics into governance, planning and resource design.

 

Quality control: Why active process management is vital for pharmaceutical, chemical and life sciences industries.

 

The key points:

  • From a queueing‑theory perspective, analytical QC laboratories are dynamic flow systems in which sample inventory, lead times, and throughput are tightly linked by physical relationships.
  • Little’s Law describes this relationship as L = λ ⋅ W making it clear that any reduction in lead time at a given throughput must be accompanied by a reduction in work in process (WIP).
  • Kingman’s formula complements this picture by adding stochastic effects and shows how utilization and variability cause waiting times in front of bottleneck resources to grow disproportionately; in approximation, the average waiting time is given by variability × utilization factor × average processing time, where the utilization factor is U/(1–U)
  • Practical examples (e.g. 60 samples per day with 2–3 days TAT) illustrate how express analyses, batch arrivals, or missing WIP limits directly influence the system parameters L, U, and V – and thus overall lab performance.

 

The article suggests that shaping these parameters is the responsibility of lab managers in their leadership and system design roles. Those who wish to achieve stable lead times and reliable delivery capability must deliberately incorporate flow physics into the governance, planning and capacity design of the QC labs.

Quality control labs in pharma, chemicals, and life sciences operate under constant pressure: rising sample volumes, more complex methods, ambitious delivery deadlines, and cost constraints under strict regulatory requirements. Little’s Law and Kingman’s formula make it clear that this is less a problem of individual productivity and more a consequence of the lab’s underlying system dynamics – and they provide a robust framework for aligning structural and leadership decisions with the principles of flow physics.

The terms turnaround time (TAT), lead time and cycle time are used synonymously throughout the following text.

 

1. Little’s Law: Foundation of Flow Physics

 

Little’s Law is a fundamental theorem of queueing theory that links three key metrics of a stationary system: the average inventory L, the average arrival rate λ, and the average time in the system W. Little’s Law states that L = λ ⋅ W. The long‑term average number of test jobs L equals the arrival rate λ multiplied by the average time in the system W

For a QC laboratory, these quantities can be interpreted directly as:

  • L: number of samples in the system (waiting, preparation, measurement, evaluation)
  • λ: analyses performed per day (effective throughput)
  • W: average time a sample spends in the system from arrival in the lab to release of the results.

 

A simple example illustrates the relevance for quality control: if a lab processes an average of 60 samples per day with an average TAT of 3 days, Little’s Law gives L = 60  ⋅ 3 = 180 samples in the system. If lead time is reduced to 2 days at the same throughput, the average inventory drops to 120 samples – a reduction of 60 simultaneously “waiting” samples without any additional capacity.​

The key assumptions are that the system is stationary, i.e. arrivals and departures do not diverge in the long run, and that the relevant averages exist. In QC laboratories with largely repetitive routines, established test plans, and relatively stable demand over weeks to months, these conditions are often well met in practice.

 

 

2. Kingman’s Formula (VUT): Utilisation, Variability, and Waiting Time

Fluss in der Qualitätskontrolle

While Little’s Law provides an identity between inventory, throughput, and time in the system, Kingman’s formula describes the average waiting time in front of a resource under realistic, fluctuating conditions. It applies to a queueing model with general arrival and service‑time distributions and a single resource (a G/G/1 system) – in other words, to the typical situation in which a single HPLC line or specific instrument must process irregular sample inflows with varying analysis durations.

Explanation: “General/General/1” (G/G/1 system) means that no specific distribution is assumed for arrivals or service times – variability is explicitly allowed and captured via a variability factor. This mirrors the reality of many QC bottlenecks: a queue in front of an instrument or team that must cope with incoming peaks, express analyses, and variable analysis durations.

The VUT equation expresses the average waiting time in the queue as the product of three key drivers:

  • variability in the system (V),
  • utilization of the resource (U),
  • and average processing time per job (T).

The utilization factor, which is formed from U and 1−U, describes the amplification effect of utilization: the closer utilization gets to 100%, the more than proportionally waiting times increase.

The variability factor V is often derived from the squared coefficients of variation of arrival and service times and aggregates the stochastic fluctuations of both into a single metric. For QC laboratory environments this has two key implications:

 

  • First, the utilization factor shows that waiting times do not rise linearly with utilization but more than proportionally and become almost asymptotic as utilization approaches 100%.
  • Second, higher fluctuations in arrivals and processing times – for example due to batch arrivals, frequent priority changes, or highly heterogeneous analysis durations – directly amplify this effect through the variability factor.

 

A simple comparison illustrates the magnitude: if utilization on a critical HPLC line increases from 80% to 95%, the corresponding utilization factor rises from about 4 to about 19. With variability and average processing time unchanged, the average waiting time can increase several‑fold – even though technology, methods, and team performance remain the same.

This explains why, in highly utilized QC laboratories, even small disruptions or additional unplanned express analyses can cause abrupt spikes in TAT.

Kingman’s formula is an approximation. It provides particularly good results under stable conditions, moderate variability, and a first‑come‑first‑served discipline. In strongly prioritized environments, with cancellations or multiple parallel bottlenecks, it can only roughly approximate actual waiting times and should therefore be interpreted with caution.

 

3. Application to Analytical QC Laboratories

 

Combining Little’s Law and Kingman’s formula yields a coherent physical picture of process dynamics in QC labs.

Little’s Law links TAT, throughput, and sample inventory and thus allows target values for work in process (WIP) and lead time to be derived, while Kingman helps to understand the role of utilization and variability for waiting times and, consequently, for observed TAT.

Typical levers in the laboratory map cleanly to these parameters:

  • WIP limits and restrictions on parallel jobs directly affect L and thus lead times via Little’s Law.
  • Capacity planning and deliberately limiting resource utilization (e.g. 75–85% instead of 95–100%) reduce the utilization factor U/(1−U) in Kingman’s formula.
  • Measures to reduce variability – standardized test plans, smoothed arrivals, clear prioritization rules – reduce the variability factor V.

The result is systematically long and volatile TAT that cannot be remedied by isolated actions such as extra meetings or stricter supervision but require adjustments to the underlying system parameters.

 

4. Leadership Task: System Design and Active Steering rather than Individual Performance

 

From a scientific perspective, Little’s Law and Kingman’s formula show that the observed performance of a QC laboratory is driven primarily by system design rather than by individual behavior.

Leaders decide on permissible WIP, target utilization, arrival planning, and prioritization logic – and thus on the key parameters L, U, and V that dominate lead time. Instead of addressing delays primarily with “more effort” or isolated efficiency programs, it is more effective from a flow‑physics perspective to make explicit design decisions:

  • defining critical WIP levels that balance maximum throughput with minimal TAT,
  • setting target utilization for bottleneck resources that allow sufficient buffer for variability,
  • designing robust control mechanisms that limit variability while still meeting regulatory requirements.

Thus, managing TAT in quality control becomes a conscious leadership decision based on well‑established queueing‑theory models, rather than merely a question of operational discipline.

 

References:

See Little, J. D. C. (1961), “A Proof for the Queuing Formula L = λW,” Operations Research, 9(3), 383–387; Little, J. D. C. (2011), “Little’s Law as Viewed on Its 50th Anniversary,” Operations Research, 59(3), 536–549; Kingman, J. F. C. (1961), “The Single Server Queue in Heavy Traffic,” Mathematical Proceedings of the Cambridge Philosophical Society, 57(4), 902–904.

 

Retention, Standardization, and Process Simplification in Pharma QC Labs: How They Shape Lab Performance

Staff retention in pharma QC labs impacts to productivity, compliance, and turn-around-times..

Complexity eats productivity and focus in the analytical lab

Analytical labs are evolving from technical service providers to strategic value drivers – under increasing pressure from complexity, regulation, and a shortage of skilled personnel. Effective laboratory leadership today requires above all one thing: clarity – in...

Are you still “busy” or already “productive”?

Auf die Frage, welchen konkreten Effekt laufende Aktivitäten auf Produktivität oder Erreichung der Ziele haben, fällt eine quantifizierbare Antwort häufig nicht leicht.

Are you living in a complexity trap?

Mehr und mehr Organisationen verstricken sich in einem Netz aus Komplexität. Was als zunächst als Streben um eine Rationalisierung der Abläufe beginnt, entwickelt sich häufig zu einem verwirrenden Labyrinth. Wie können Sie dafür sorgen, dass die einzelnen Rädchen wieder perfekt ineinander greifen?